The Antimicrobial Resistance (AMR) Phage Laboratory focuses primarily on the isolation, characterisation, and translational application of bacteriophages against multidrug-resistant (MDR) bacteria. The laboratory integrates classical microbiology with molecular biology and genomics to identify lytic phages from environmental sources like sewage, wastewater, and soil.  The lab focuses on phage enrichment, plaque purification, host- range determination, adsorption kinetics, one-step growth analysis, biofilm inhibition studies, and genomic characterisation to assess phage safety and therapeutic potential. Key focus will be given to clinically relevant AMR pathogens, including Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Escherichia coli.  Our facility aims to develop safe, targeted, and sustainable phage-based interventions as alternative or adjunct therapies to combat the growing global burden of antimicrobial resistance.